| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7195bcefe9a7b39dcd91a1f2988bac68 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-32 |
| filingDate |
2009-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc877109ed13a01c3e6b0cc64931b28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296ef60c5e4b692a1c96b7dfe736d310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d170286b03e92e27a257c1dd2806aec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f6f6c905e12530e8f081620d50932e1 |
| publicationDate |
2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2486921-C2 |
| titleOfInvention |
Haemostatic composition containing hyaluronic acid |
| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine. What is described is a haemostatic composition containing a biologically absorbable material and hyaluronic acid or a derivative thereof. There are described methods for preparing the given compositions, and there are described the applications of the given compositions. Particularly, the method for preparing the above haemostatic composition involves the dry heat treatment at temperature 110 to 200°C. n EFFECT: compositions exhibit the enhanced haemostatic properties. n 68 cl, 1 tbl, 8 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2744694-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2705812-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2659175-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2709816-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246958-B2 |
| priorityDate |
2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |